XML 88 R93.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION PLANS (Combined Activity for Stock Appreciation Rights and Stock Options Excluding the Cash Component) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding, number, ending balance 1,437,031    
Exercisable, number 1,018,397    
Outstanding, weighted average exercise price, ending balance $ 19.85    
Exercisable, weighted average exercise price $ 22.95    
Outstanding, weighted average remaining contractual life (years) 2 years 8 months 23 days    
Exercisable, weighted average remaining contractual life (years) 2 years 1 month 1 day    
Stock appreciation rights and stock options excluding the cash component
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding, number, beginning balance 2,653,430 2,930,492 2,807,498
Granted, number 0 185,004 828,463
Exercised, number (223,473) (4,105) (361,478)
Forfeited / expired, number (992,926) (457,961) (343,991)
Outstanding, number, ending balance 1,437,031 2,653,430 2,930,492
Exercisable, number 1,018,397    
Outstanding, weighted average exercise price, beginning balance $ 24.07 $ 24.81 $ 27.45
Granted, weighted average exercise price $ 0.00 $ 14.25 $ 11.63
Exercised, weighted average exercise price $ 11.84 $ 11.60 $ 12.34
Forfeited / expired, weighted average exercise price $ 32.93 $ 24.91 $ 27.78
Outstanding, weighted average exercise price, ending balance $ 19.85 $ 24.07 $ 24.81
Exercisable, weighted average exercise price $ 22.95    
Outstanding, weighted average remaining contractual life (years) 2 years 8 months 23 days 2 years 9 months 18 days 3 years 3 months 18 days
Exercisable, weighted average remaining contractual life (years) 2 years 1 month 1 day    
Outstanding, aggregated intrinsic value $ 4,384,668 $ 2,867,175 $ 1,104,590
Exercisable, aggregated intrinsic value $ 2,307,463    
Remaining unvested stock appreciation rights and stock options expected to vest, number 397,703    
Remaining unvested options and SARs expected to vest, weighted average exercise price $ 12.32